We were able to confirm the characteristic increase in HCM size with PMA treatment (Figure 1A), as well as demonstrate an increase in both mRNA (Figure 1D) and protein expression (Figure 1C) of BNP, the clinical HF biomarker. The gene discussed is NPPB; the disease is hydrops fetalis.